Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Patients who have no residual invasive cancer following neoadjuvant chemotherapy for breast carcinoma have a better overall survival than those with residual disease. Many classification systems assessing pathological response to neoadjuvant chemotherapy include residual ductal carcinoma in situ (DC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jones, R L, Lakhani, S R, Ring, A E, Ashley, S, Walsh, G, Smith, I E
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2006
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361141/
https://ncbi.nlm.nih.gov/pubmed/16421590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602950
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items